US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist
  • 7.900
  • +0.320+4.22%
Close Mar 28 16:00 ET
  • 7.900
  • 0.0000.00%
Post 16:05 ET
154.30MMarket Cap-5.65P/E (TTM)

Actuate Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
0.75%25.16M
-13.87%6.56M
-16.72%5.39M
-2.67%5.44M
46.71%7.77M
23.59%24.97M
7.62M
6.48M
5.58M
5.3M
Selling and administrative expenses
98.57%6.48M
196.40%2.87M
129.05%1.64M
31.65%1.06M
17.81%912.82K
-14.51%3.27M
--969.35K
--714.17K
--807.18K
--774.8K
-General and administrative expense
98.57%6.48M
196.40%2.87M
129.05%1.64M
31.65%1.06M
17.81%912.82K
-14.51%3.27M
--969.35K
--714.17K
--807.18K
--774.8K
Research and development costs
-13.97%18.68M
-44.54%3.69M
-34.79%3.76M
-8.47%4.37M
51.65%6.86M
32.47%21.71M
--6.65M
--5.76M
--4.78M
--4.52M
Operating profit
-0.75%-25.16M
13.87%-6.56M
16.72%-5.39M
2.67%-5.44M
-46.71%-7.77M
-23.59%-24.97M
-7.62M
-6.48M
-5.58M
-5.3M
Net non-operating interest income expense
-34.12%203.58K
106.94%113.04K
-36.09%77.26K
-96.77%3.57K
-58.14%9.71K
2,754.26%309.03K
54.63K
120.88K
110.33K
23.2K
Non-operating interest income
-36.97%222.29K
97.89%118.12K
-35.89%80.75K
-92.51%8.65K
-71.37%14.79K
1,204.89%352.67K
--59.69K
--125.94K
--115.39K
--51.65K
Non-operating interest expense
-57.11%18.72K
0.26%5.08K
-31.07%3.49K
0.28%5.08K
-82.16%5.08K
169.39%43.64K
--5.06K
--5.06K
--5.06K
--28.45K
Other net income (expense)
-2,816.70%-2.33M
0
-3,985.43%-655.32K
-2,171.86%-1.14M
-10,533.29%-532.52K
-318.22%-79.82K
-51.6K
16.87K
-50.19K
5.1K
Gain on sale of security
431.16%264.34K
--0
3,085.05%537.19K
-378.82%-240.34K
-737.05%-32.52K
-318.22%-79.82K
---51.6K
--16.87K
---50.19K
--5.1K
Other non- operating income (expenses)
---2.59M
--0
---1.19M
---900K
---500K
----
----
----
----
----
Income before tax
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-7.61M
-6.34M
-5.52M
-5.27M
Income tax
Net income
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-7.61M
-6.34M
-5.52M
-5.27M
Net income continuous Operations
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
---7.61M
---6.34M
---5.52M
---5.27M
Minority interest income
Net income attributable to the parent company
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-7.61M
-6.34M
-5.52M
-5.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
-22.74%-24.74M
-7.61M
-6.34M
-5.52M
-5.27M
Basic earnings per share
-151.79%-3.26
17.14%-0.33
-34.42%-0.55
3.58%-0.3439
-58.71%-0.54
3.45%-1.2947
-0.3983
-0.4092
-0.3566
-0.3402
Diluted earnings per share
-151.79%-3.26
17.14%-0.33
-34.42%-0.55
3.58%-0.3439
-58.71%-0.54
3.45%-1.2947
-0.3983
-0.4092
-0.3566
-0.3402
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 0.75%25.16M-13.87%6.56M-16.72%5.39M-2.67%5.44M46.71%7.77M23.59%24.97M7.62M6.48M5.58M5.3M
Selling and administrative expenses 98.57%6.48M196.40%2.87M129.05%1.64M31.65%1.06M17.81%912.82K-14.51%3.27M--969.35K--714.17K--807.18K--774.8K
-General and administrative expense 98.57%6.48M196.40%2.87M129.05%1.64M31.65%1.06M17.81%912.82K-14.51%3.27M--969.35K--714.17K--807.18K--774.8K
Research and development costs -13.97%18.68M-44.54%3.69M-34.79%3.76M-8.47%4.37M51.65%6.86M32.47%21.71M--6.65M--5.76M--4.78M--4.52M
Operating profit -0.75%-25.16M13.87%-6.56M16.72%-5.39M2.67%-5.44M-46.71%-7.77M-23.59%-24.97M-7.62M-6.48M-5.58M-5.3M
Net non-operating interest income expense -34.12%203.58K106.94%113.04K-36.09%77.26K-96.77%3.57K-58.14%9.71K2,754.26%309.03K54.63K120.88K110.33K23.2K
Non-operating interest income -36.97%222.29K97.89%118.12K-35.89%80.75K-92.51%8.65K-71.37%14.79K1,204.89%352.67K--59.69K--125.94K--115.39K--51.65K
Non-operating interest expense -57.11%18.72K0.26%5.08K-31.07%3.49K0.28%5.08K-82.16%5.08K169.39%43.64K--5.06K--5.06K--5.06K--28.45K
Other net income (expense) -2,816.70%-2.33M0-3,985.43%-655.32K-2,171.86%-1.14M-10,533.29%-532.52K-318.22%-79.82K-51.6K16.87K-50.19K5.1K
Gain on sale of security 431.16%264.34K--03,085.05%537.19K-378.82%-240.34K-737.05%-32.52K-318.22%-79.82K---51.6K--16.87K---50.19K--5.1K
Other non- operating income (expenses) ---2.59M--0---1.19M---900K---500K--------------------
Income before tax -10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-7.61M-6.34M-5.52M-5.27M
Income tax
Net income -10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-7.61M-6.34M-5.52M-5.27M
Net income continuous Operations -10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M---7.61M---6.34M---5.52M---5.27M
Minority interest income
Net income attributable to the parent company -10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-7.61M-6.34M-5.52M-5.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M-22.74%-24.74M-7.61M-6.34M-5.52M-5.27M
Basic earnings per share -151.79%-3.2617.14%-0.33-34.42%-0.553.58%-0.3439-58.71%-0.543.45%-1.2947-0.3983-0.4092-0.3566-0.3402
Diluted earnings per share -151.79%-3.2617.14%-0.33-34.42%-0.553.58%-0.3439-58.71%-0.543.45%-1.2947-0.3983-0.4092-0.3566-0.3402
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More